Hemimegalencephaly, a paradigm for somatic postzygotic neurodevelopmental disorders
Authors:
- Seung Tae BaekSBSeung Tae Baek
- Elizabeth M. GibbsEGElizabeth M. Gibbs
- Joseph G. GleesonJGJoseph G. Gleeson
- Gary W. MathernGMGary W. Mathern
- 1 April 2013
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 26 (2) , 122-127
Abstract
Combining human genomics and molecular biology, recent studies have made pivotal progress toward understanding the cause of hemimegalencephaly (HME) and other cerebral megalencephaly syndromes. The present article highlights recent advances of the genetic cause of these conditions, and considers the role of somatic postzygotic genetic lesions in brain maldevelopment. Studies over the past 12 months have identified de-novo somatic mutations as one possible cause in HME. The gene mutations involve components of the phosphatidylinositol 3-kinase (PI3K)-AKT (also known as protein kinase B)-mammalian target of rapamycin (mTOR) pathway and include PIK3CA, PIK3R2, AKT3, and MTOR. These mutations were identified by comparing genomic data obtained from surgically resected brain tissue with nondiseased tissue, and by single-neuron sequencing in combination with molecular biology techniques. The association between the somatic mutations and downstream activation of the PI3K-mTOR pathway suggests that HME is a neurodevelopmental disease caused by gain-of-function activation of the PI3K-AKT-mTOR pathway. The studies reviewed suggest that somatic mutations of the PI3K-AKT-mTOR pathway limited to the brain may represent one cause of HME. Dysregulation of this pathway has possible therapeutic potential in the identification of HME. Somatic mutations may be an important yet underappreciated disease mechanism in developmental neurological diseases.Keywords
This publication has 33 references indexed in Scilit:
- Hemimegalencephaly Associated with Congenital Infiltrating Lipomatosis of the Face: A Case ReportNeuropediatrics, 2012
- Hemimegalencephalic variant of epidermal nevus syndrome: Case report and literature reviewEuropean Journal of Paediatric Neurology, 2012
- De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndromeNature Genetics, 2012
- De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndromeNature Genetics, 2011
- Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutationsNature Genetics, 2011
- De novo mutations of SETBP1 cause Schinzel-Giedion syndromeNature Genetics, 2010
- Contralateral hemimicrencephaly and clinical–pathological correlations in children with hemimegalencephalyBrain, 2005
- Hemimegalencephaly and tuberous sclerosis complexNeurology, 2005
- Proteus syndrome: craniofacial and cerebral MRINeuroradiology, 1999
- Hemimegalencephaly and NeurofibromatosisNeuropediatrics, 1990